Indications
Rabsil is indicated for the treatment of active duodenal ulcer, active benign gastric ulcer, and symptomatic erosive or ulcerative gastro-esophageal reflux disease (GERD). It is also used for the long-term management of GERD (GERD maintenance) and for the symptomatic treatment of moderate to very severe gastro-esophageal reflux disease (symptomatic GERD). Other indications include Zollinger-Ellison syndrome, as well as, in combination with appropriate antibacterial regimens, the eradication of Helicobacter pylori in patients with peptic ulcer disease.
⚠️ Always consult a registered physician before taking any medicine.
Pharmacology
Rabeprazole reduces the secretion of gastric acid by blocking the H+/K+-ATPase enzyme at the secretory surface of the gastric parietal cell. Since this enzyme is regarded as the acid (proton) pump within the parietal cell, Rabeprazole is described as a gastric proton-pump inhibitor.
Pregnancy & Breastfeeding
US FDA pregnancy category 'C'. Studies have been performed in animals and have revealed no evidence of impaired fertility or harm to the fetus due to Rabeprazole. There are however, no adequate and well-controlled studies in pregnant women. Rabeprazole is likely to be excreted in human milk, a decision should be made whether to discontinue nursing or to discontinue the drug, taking into account the importance of the drug to the mother.
⚠️ Talk to your doctor before taking any medicine during pregnancy or while breastfeeding.
Dosage Reference
⚠️ Reference ranges from official sources only. Consult your doctor for personalized dosing.
Side Effects & Interactions
Side Effects
No side-effect data recorded yet.